AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
OHI
ACCE-researched

Omega Healthcare Investors Inc. Common Stock (OHI) fair value

Real Estate · REIT - Healthcare Facilities · NYSE · United States
$46.23-0.15%
Market cap $14.6BNext earnings 2026-11-03Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 28% above our fair value
Price
$46.23
Model fair valueConfidence: good
$36.09
Model range
$34.13 to $38.06
Fair value $36.09
Price $46.23
2 models fit Omega Healthcare Investors Inc. Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Premium(i)Bronze51
Valued as a REIT (property company): Price to FFO and EV/EBITDA comparison.
ACCE opinionOmega Healthcare Investors Inc. Common Stock (OHI)
Fair value (2 models)
$36.09
ACCE price target
$45.00
Rating
Overvalued
Horizon
12 months
Fair value published on 11 Oct 2026, 00:00 CEST; previously $33.80 since 21 Sept 2026, 00:00 CEST.
ACCE price target published on 26 Sept 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 19:04 CEST.
Price used: $46.23 at the close on 23 Oct 2026, 22:00 CEST.
Models: EV/EBITDA comparison and Price to FFO.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
28.1% above
-21.9% to fair value
ACCE score
68
out of 100
Analysts
40% buy
20 covering
P/E
16.5x
forward 22.7x
1-year return
+13.6%
Dividend yield
5.87%

Omega Healthcare Investors Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Omega Healthcare Investors owns and leases skilled nursing facilities and other healthcare real estate, collecting rent from operators such as Genesis and Ensign under long-term master leases. Its moat is structural: a diversified portfolio of roughly 900 facilities with long lease terms and escalators, and a 97.9% gross margin that reflects a pure rental model with little operating cost. Near-term growth rests on acquisitions and capital recycling into newer, better-located facilities, which lifted revenue 11.2% in the period under review. At a 16.2x trailing P/E and 61.5% operating margin, the stock trades at a discount to its 22.4x forward multiple, which implies the market expects earnings to dip before recovering, so the forward estimates deserve scrutiny. Operator-level tenant health in skilled nursing remains the key risk to rent coverage and should be the first item in any deeper review.

AI-assisted·How I use AIWritten Oct 14, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Forward P/E expansion
    Forward P/E of 22.0 vs current 15.9 signals earnings deceleration. QoQ revenue declined 1.5% despite 11.2% YoY growth, suggesting momentum loss.
  • moderate
    Quality score weakness
    ACCE Quality subscore at 86 is strong, but Momentum at 47 is materially weak. Score declined 3 points in 90 days, indicating deteriorating trends.
  • moderate
    Valuation multiple compression risk
    Wide range ($36-$54) reflects model uncertainty in a slowing growth environment.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue has grown 11.2% year over year with a 10.3% five year average, showing consistent expansion.
  • Net margin of 68.1% and ROE of 16.5% demonstrate strong operational efficiency and capital returns.
  • Dividend yield of 6.2% with $666M free cash flow supports distributions while analyst mean target is $51.78 versus current $44.41.
Why it could disappoint
  • ROIC of 5.0% lags the cost of capital, meaning invested dollars destroy shareholder value over time.
  • Share count diluted 14.9% last fiscal year, eroding per share value even as total earnings grew.
  • Consensus fair value is $35.97 versus $44.41 price, a 19.0% overvaluation, with forward P/E of 22.0x versus trailing 15.9x.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 3, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where OHI's valuation models land
Price
$46.23
Model fair value
$36.09
Model range
$34.13 to $38.06
Fair value $36.09
Price $46.23
The price is above the whole model range.
Model
Fair value
Upside
EV/EBITDA comparison
Price to FFO
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed40% buy · 20 covering analysts
● Strong buy 6● Buy 2● Hold 10● Sell 2● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+1.3%
1 month
+0.1%
3 months
-10.6%
6 months
-0.4%
YTD
+4.3%
1 year
+13.6%

SEC filings

Held by ETFs

ETFs we cover that hold Omega Healthcare Investors Inc. Common Stock among their largest holdings, by weight.

  • IYR · iShares US Real Estate ETF1.1% of the fund
  • SCHH · Schwab US REIT ETF1.0% of the fund
Holdings as of 2026-10-24

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 19:04 CESTRatingOvervaluedfirst publication$45.64
11 Oct 2026, 00:00 CESTFair value$35.97$33.80$44.41
26 Sept 2026, 00:00 CESTACCE price target$45.00first publication$46.28
21 Sept 2026, 00:00 CESTFair value$33.80$34.64$46.66
14 Sept 2026, 00:00 CESTFair value$34.64$36.00$46.99
10 Sept 2026, 00:00 CESTFair value$36.00$34.98$47.03
5 Sept 2026, 00:00 CESTFair value$34.98$36.28$47.04
3 Sept 2026, 00:00 CESTFair value$36.28$35.20$46.79
31 Aug 2026, 00:00 CESTFair value$35.20$31.37$45.99
26 Aug 2026, 00:00 CESTFair value$31.37$30.96$46.69

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full OHI page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value69Quality81Momentum47Total68
Valuation
Trailing P/E
16.5x
Forward P/E
22.7x
PEG
0.10
P/B
2.60x
EV / Revenue
14.2x
Book value/sh
$18.02
Enterprise value
$18.0B
Profitability
ROE
16.5%
FCF yield
6.03%
ROIC
5.1%
Health and risk
Debt / equity
0.82
Dividend yield
5.87%
Beta
0.53

Price

+14.2% · 1Y

Ask anything about OHI

Answered from Omega Healthcare Investors Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 83% of peers
low 0.0x16.5xhigh 160.7x
ROEbetter than 100% of peers
low -2%17%high 17%
Div yieldbetter than 67% of peers
low 1.9%5.9%high 6.3%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
OHI Omega Healthcare Investors Inc. Common Stock$46.23$3628% above16.5x16.5%8168
DOC Healthpeak Properties Inc. Common Stock$19.25--55.0x3.0%5761
AHR American Healthcare REIT Inc. Common Stock$53.02--79.1x4.0%4356
CTRE CareTrust REIT Inc. Common Stock$36.62$2175% above22.9x9.1%8566
HR Healthcare Realty Trust Incorporated Common Stock$17.95$1165% above--1.9%4736
SBRA Sabra Health Care REIT Inc. Common Stock$19.56--78.2x2.4%4445
VTR Ventas Inc. Common Stock$86.80--160.7x2.0%4649

Sector report card

Where OHI ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 5, 2026
    Omega to Transition Operations of 32 Facilities in Florida to PACS Group
  • Business Wire•Sep 18, 2026
    Omega Announces Third Quarter Earnings Release Date and Conference Call
  • Business Wire•Sep 1, 2026
    PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities
2 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 5
8-KCurrent reportPeriod 2026-10-05
View on SEC →
Oct 1
8-KCurrent reportPeriod 2026-10-01
View on SEC →
Oct 1
Form 4Insider transactionPeriod 2026-09-30
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR